ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Underexpression of class II histocompatibility antigens (HLA) is related with poor prognosis in childhood adrenocortical tumors (ACT) (2012)
Leite, Fabíola; Lira, Régia Caroline Peixoto; Fedatto, Paola Fernanda; Martinelli Junior, Carlos Eduardo; Antonini, Sonir Roberto Rauber; Custódio, Rodrigo José; Castro, Margaret de; Tucci Júnior, Silvio; Serafini, Luciano Neder; Ramalho, Leandra Naíra Zambelli; Seidinger, Ana; Cardinalli, Izilda; Mastellaro, Maria José; Yunes, José A.; Brandalise, Sílvia; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: Hormone Research in Paediatrics. Conference titles: Annual Meeting of the European Society for Paediatric Endocrinology (ESPE). Unidade: FMRP
Subjects: NEOPLASIAS DAS GLÂNDULAS SUPRARRENAIS, CRIANÇAS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Fabíola et al. Underexpression of class II histocompatibility antigens (HLA) is related with poor prognosis in childhood adrenocortical tumors (ACT). Hormone Research in Paediatrics. Basel: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2012
APA
Leite, F., Lira, R. C. P., Fedatto, P. F., Martinelli Junior, C. E., Antonini, S. R. R., Custódio, R. J., et al. (2012). Underexpression of class II histocompatibility antigens (HLA) is related with poor prognosis in childhood adrenocortical tumors (ACT). Hormone Research in Paediatrics. Basel: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Leite F, Lira RCP, Fedatto PF, Martinelli Junior CE, Antonini SRR, Custódio RJ, Castro M de, Tucci Júnior S, Serafini LN, Ramalho LNZ, Seidinger A, Cardinalli I, Mastellaro MJ, Yunes JA, Brandalise S, Tone LG, Scrideli CA. Underexpression of class II histocompatibility antigens (HLA) is related with poor prognosis in childhood adrenocortical tumors (ACT). Hormone Research in Paediatrics. 2012 ; 78( suppl. 1): 20-21.[citado 2024 out. 31 ]
Vancouver
Leite F, Lira RCP, Fedatto PF, Martinelli Junior CE, Antonini SRR, Custódio RJ, Castro M de, Tucci Júnior S, Serafini LN, Ramalho LNZ, Seidinger A, Cardinalli I, Mastellaro MJ, Yunes JA, Brandalise S, Tone LG, Scrideli CA. Underexpression of class II histocompatibility antigens (HLA) is related with poor prognosis in childhood adrenocortical tumors (ACT). Hormone Research in Paediatrics. 2012 ; 78( suppl. 1): 20-21.[citado 2024 out. 31 ]
Trabalho de evento-resumo periodico
Abnormal activation of the Wint/β-catenin pathway in childhood adrenocortical tumors (ACTs) (2011)
Leal, Letícia Ferro; Mermejo, Lívia Mara; Ramalho, Leandra Naíra Zambelli; Martinelli Junior, Carlos Eduardo; Yunes, Jose Andres; Seidinger, Ana Luiza; Mastellaro, Maria José; Brandalise, Silvia Regina; Moreira, Ayrton Custódio; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto; Castro, Margaret de; Antonini, Sonir Roberto Rauber
Source: Hormone Research in Paediatrics. Conference titles: Annual Meeting of the European Society for Paediatric Endocrinology (ESPE). Unidade: FMRP
Subjects: CRIANÇAS, MUTAÇÃO GENÉTICA, ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Letícia Ferro et al. Abnormal activation of the Wint/β-catenin pathway in childhood adrenocortical tumors (ACTs). Hormone Research in Paediatrics. Basel: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2011
APA
Leal, L. F., Mermejo, L. M., Ramalho, L. N. Z., Martinelli Junior, C. E., Yunes, J. A., Seidinger, A. L., et al. (2011). Abnormal activation of the Wint/β-catenin pathway in childhood adrenocortical tumors (ACTs). Hormone Research in Paediatrics. Basel: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Leal LF, Mermejo LM, Ramalho LNZ, Martinelli Junior CE, Yunes JA, Seidinger AL, Mastellaro MJ, Brandalise SR, Moreira AC, Tone LG, Scrideli CA, Castro M de, Antonini SRR. Abnormal activation of the Wint/β-catenin pathway in childhood adrenocortical tumors (ACTs). Hormone Research in Paediatrics. 2011 ;76( suppl.2): 33.[citado 2024 out. 31 ]
Vancouver
Leal LF, Mermejo LM, Ramalho LNZ, Martinelli Junior CE, Yunes JA, Seidinger AL, Mastellaro MJ, Brandalise SR, Moreira AC, Tone LG, Scrideli CA, Castro M de, Antonini SRR. Abnormal activation of the Wint/β-catenin pathway in childhood adrenocortical tumors (ACTs). Hormone Research in Paediatrics. 2011 ;76( suppl.2): 33.[citado 2024 out. 31 ]
Trabalho de evento-resumo
Effect of DHMEQ, a NF-kappaB inhibitor, on nasal fibroblasts polyps cultures (2010)
Valera, Fabiana Cardoso Pereira; Umezawa, K.; Brassesco, M. S.; Gamero, A. M. C.; Cortez, M. A.; Queiroz, R. P.; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Demarco, R. C.; Anselmo-Lima, Wilma Terezinha
Source: Abstracts Book. Conference titles: Congress of The European Rhinologic Society. Unidade: FMRP
Subjects: PÓLIPOS NASAIS, FIBROBLASTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALERA, Fabiana Cardoso Pereira et al. Effect of DHMEQ, a NF-kappaB inhibitor, on nasal fibroblasts polyps cultures. 2010, Anais.. Geneva: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2010. . Acesso em: 31 out. 2024.
APA
Valera, F. C. P., Umezawa, K., Brassesco, M. S., Gamero, A. M. C., Cortez, M. A., Queiroz, R. P., et al. (2010). Effect of DHMEQ, a NF-kappaB inhibitor, on nasal fibroblasts polyps cultures. In Abstracts Book. Geneva: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Valera FCP, Umezawa K, Brassesco MS, Gamero AMC, Cortez MA, Queiroz RP, Scrideli CA, Tone LG, Demarco RC, Anselmo-Lima WT. Effect of DHMEQ, a NF-kappaB inhibitor, on nasal fibroblasts polyps cultures. Abstracts Book. 2010 ;[citado 2024 out. 31 ]
Vancouver
Valera FCP, Umezawa K, Brassesco MS, Gamero AMC, Cortez MA, Queiroz RP, Scrideli CA, Tone LG, Demarco RC, Anselmo-Lima WT. Effect of DHMEQ, a NF-kappaB inhibitor, on nasal fibroblasts polyps cultures. Abstracts Book. 2010 ;[citado 2024 out. 31 ]
Artigo de periodico
Increased risk for acute lymphoblastic leukemia in children with cytochrome 'P IND.450' 'A IND.1' (CYP1A1)- and NAD(P)H: quinone oxidoreductase 1 (NQO1)- inherited gene variants (2010)
Yamagutti, Gabriela G.; Silveira, Vanessa da Silva; Tone, Luiz Gonzaga; Lopes, Luiz Fernando; Lima, Carmen Silvia Passos; Lourenço, Gustavo Jacob
Source: Acta Haematologica. Unidade: FMRP
Subjects: LEUCEMIA, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YAMAGUTTI, Gabriela G. et al. Increased risk for acute lymphoblastic leukemia in children with cytochrome 'P IND.450' 'A IND.1' (CYP1A1)- and NAD(P)H: quinone oxidoreductase 1 (NQO1)- inherited gene variants. Acta Haematologica, v. 124, n. 3, p. 182-184, 2010Tradução . . Acesso em: 31 out. 2024.
APA
Yamagutti, G. G., Silveira, V. da S., Tone, L. G., Lopes, L. F., Lima, C. S. P., & Lourenço, G. J. (2010). Increased risk for acute lymphoblastic leukemia in children with cytochrome 'P IND.450' 'A IND.1' (CYP1A1)- and NAD(P)H: quinone oxidoreductase 1 (NQO1)- inherited gene variants. Acta Haematologica, 124( 3), 182-184.
NLM
Yamagutti GG, Silveira V da S, Tone LG, Lopes LF, Lima CSP, Lourenço GJ. Increased risk for acute lymphoblastic leukemia in children with cytochrome 'P IND.450' 'A IND.1' (CYP1A1)- and NAD(P)H: quinone oxidoreductase 1 (NQO1)- inherited gene variants. Acta Haematologica. 2010 ; 124( 3): 182-184.[citado 2024 out. 31 ]
Vancouver
Yamagutti GG, Silveira V da S, Tone LG, Lopes LF, Lima CSP, Lourenço GJ. Increased risk for acute lymphoblastic leukemia in children with cytochrome 'P IND.450' 'A IND.1' (CYP1A1)- and NAD(P)H: quinone oxidoreductase 1 (NQO1)- inherited gene variants. Acta Haematologica. 2010 ; 124( 3): 182-184.[citado 2024 out. 31 ]
Artigo de periodico
Analysis of ETV6/RUNX1 fusions for evaluating the late effects of cancer therapy in ALL (acute lymphoblastic leukemia) cured patients (2004)
Brassesco, M. S.; Camparoto, M. L.; Tone, Luiz Gonzaga; Sakamoto-Hojo, Elza Tiemi
Source: Cytogenetic and Genome Research. Unidades: FMRP, FFCLRP
Assunto: GENÉTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, M. S. et al. Analysis of ETV6/RUNX1 fusions for evaluating the late effects of cancer therapy in ALL (acute lymphoblastic leukemia) cured patients. Cytogenetic and Genome Research, v. 104, p. 346-351, 2004Tradução . . Disponível em: https://doi.org/10.1159/000077514. Acesso em: 31 out. 2024.
APA
Brassesco, M. S., Camparoto, M. L., Tone, L. G., & Sakamoto-Hojo, E. T. (2004). Analysis of ETV6/RUNX1 fusions for evaluating the late effects of cancer therapy in ALL (acute lymphoblastic leukemia) cured patients. Cytogenetic and Genome Research, 104, 346-351. doi:10.1159/000077514
NLM
Brassesco MS, Camparoto ML, Tone LG, Sakamoto-Hojo ET. Analysis of ETV6/RUNX1 fusions for evaluating the late effects of cancer therapy in ALL (acute lymphoblastic leukemia) cured patients [Internet]. Cytogenetic and Genome Research. 2004 ; 104 346-351.[citado 2024 out. 31 ] Available from: https://doi.org/10.1159/000077514
Vancouver
Brassesco MS, Camparoto ML, Tone LG, Sakamoto-Hojo ET. Analysis of ETV6/RUNX1 fusions for evaluating the late effects of cancer therapy in ALL (acute lymphoblastic leukemia) cured patients [Internet]. Cytogenetic and Genome Research. 2004 ; 104 346-351.[citado 2024 out. 31 ] Available from: https://doi.org/10.1159/000077514

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Indexado em